Charles River Laboratories International (CRL) Revenue — Quarter Ended Mar 30, 2024
Revenue for the quarter decreased from both the immediately preceding quarter and the same period a year ago. The sequential decline was marginal, while the year-over-year decline was more pronounced.
Key takeaway
Quarter ended Mar 30, 2024 · FY2024 Q1
Revenue for the quarter decreased from both the immediately preceding quarter and the same period a year ago. The sequential decline was marginal, while the year-over-year decline was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
-0.2%
Change from the immediately preceding quarter.
Year-over-year
-1.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jul 1, 2023 | $1.1B | +8.9% |
| Sep 30, 2023 | $1B | +3.8% |
| Dec 30, 2023 | $1B | -7.9% |
| Mar 30, 2024 | $1B | -1.7% |
Revenue performance
Reported revenue moved lower compared with the prior quarter, continuing a pattern of reduced top-line results.
Quarterly comparison
Revenue was slightly lower than the preceding quarter and fell by a larger margin compared with the same quarter one year earlier. The year-over-year decline follows a similar contraction in the previous quarter.
What to watch
This marks the second consecutive quarter with a year-over-year revenue decline.